KML001, a Telomere-Targeting Drug, Sensitizes Glioblastoma Cells to Temozolomide Chemotherapy and Radiotherapy through DNA Damage and ApoptosisSeon Rang Woo, Do‐Hyun Nam|BioMed Research International|2014Cited by 23